Global Salivary Gland Infection Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Treatment;

Medications, Surgery, Aspiration, Home Care and Others.

By End Use;

Hospitals & Clinics, Medical Research Centers, Academic Institutes and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn284689875 Published Date: June, 2024 Updated Date: July, 2024

Introduction

Global Salivary Gland Infection Market (USD Million), 2020 - 2030

In the year 2023, the Global Salivary Gland Infection Market was valued at USD 3,180.26 million. The size of this market is expected to increase to USD 5,007.42 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.7%.

The global salivary gland infection market encompasses a range of conditions affecting the salivary glands, including viral and bacterial infections, as well as inflammatory disorders. Salivary gland infections can occur in the major salivary glands, such as the parotid and submandibular glands, as well as the minor salivary glands located throughout the oral cavity. These infections often manifest with symptoms such as pain, swelling, and difficulty in saliva production, which can significantly impact patients' quality of life.

The market for salivary gland infection treatments is primarily driven by the prevalence of conditions such as viral parotitis (mumps) and bacterial sialadenitis. Viral infections, particularly mumps, remain a significant contributor to salivary gland infections, despite the availability of vaccines. Additionally, factors such as poor oral hygiene, dehydration, and immunocompromised states can increase the risk of bacterial sialadenitis, leading to a growing demand for effective treatments and management strategies.

While antibiotics are commonly prescribed for bacterial sialadenitis, the treatment approach for salivary gland infections may vary depending on the underlying cause and severity of the condition. In addition to antibiotic therapy, supportive measures such as hydration, warm compresses, and pain management are often employed to alleviate symptoms and promote healing. Surgical intervention may be necessary in cases of severe or recurrent infections, particularly when complications such as abscess formation occur. As research continues to improve our understanding of salivary gland infections and their management, the global market for salivary gland infection treatments is expected to witness advancements in diagnostic techniques, therapeutic options, and patient care strategies.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment
    2. Market Snapshot, By End Use
    3. Market Snapshot, By Region
  4. Global Salivary Gland Infection Market
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Prevalence of viral and bacterial infections
        2. Growing demand for effective treatments
        3. Advancements in diagnostic techniques
      2. Restraints
        1. Antibiotic resistance
        2. Limited awareness and diagnosis
        3. Variability in treatment response
      3. Opportunities
        1. Development of novel therapies
        2. Expansion of preventive measures
        3. Integration of telemedicine
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Salivary Gland Infection Market, By Treatment, 2020 - 2030 (USD Million)
      1. Medications
      2. Surgery
      3. Aspiration
      4. Home Care
      5. Others
    2. Global Salivary Gland Infection Market, By End Use, 2020 - 2030 (USD Million)
      1. Hospitals & Clinic
      2. Medical Research Centers
      3. Academic Institutes
      4. Others
    3. Global Salivary Gland Infection Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. GlaxoSmithKline plc
      2. Pfizer Inc.
      3. Novartis AG
      4. AstraZeneca plc
      5. Merck & Co., Inc.
      6. Sanofi S.A.
      7. Johnson & Johnson
      8. Bayer AG
      9. Abbott Laboratories
      10. Eli Lilly and Company
  7. Analyst Views
  8. Future Outlook of the Market